Back to RLMD
GOLDMAN SACHS GROUP INC → RLMD
GOLDMAN SACHS GROUP INC RLMD Position History
Relmada Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$500K
Q3 2026
Peak value
$4.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $700K |
| Q4 2025 | $117K |
| Q4 2025 | $700K |
| Q4 2025 | $117K |
| Q1 2026 | $4.9M |
| Q1 2026 | $169K |
| Q2 2026 | $4.4M |
| Q2 2026 | $866K |
| Q3 2026 | $2.8M |
| Q3 2026 | $500K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $500K | 132.7K | — | — |
| Q3 2026 | $2.8M | 748.2K | — | — |
| Q2 2026 | $866K | 125.1K | — | — |
| Q2 2026 | $4.4M | 642.5K | — | — |
| Q1 2026 | $169K | 24.3K | — | — |
| Q1 2026 | $4.9M | 699.0K | — | — |
| Q4 2025 | $117K | 24.3K | — | — |
| Q4 2025 | $700K | 145.0K | — | — |
| Q4 2025 | $117K | 24.3K | — | — |
| Q4 2025 | $700K | 145.0K | — | — |